Centre set to roll out vaccine drive to fight cervical cancer

Syllabus: GS-III;

Subject: Technology;

Topic: Services relating to Health.

Context: The Indian government plans to roll out a human papillomavirus (HPV) vaccination campaign for girls aged 9-14 to combat cervical cancer.

Issue: Vaccination for cervical cancer.


  1. The vaccine not only targets cervical cancer but also protects against HPV strains causing cancer in the anus, vagina, oropharynx, and genital warts.
  2. Aims to immunize one-third of girls aged 9-14 each year over three years, with a total target of nearly 8 crore children across the country.
  3. India accounts for about 20% of global cervical cancer cases, with 1.25 lakh new cases and 75,000 deaths annually, making it the second most common cancer among women in the country.
  4. The vaccine, Cervavac, developed by the Serum Institute of India, is quadrivalent, offering protection against HPV strains.
  5. The National Technical Advisory Group on Immunization (NTAGI) has recommended ICMR to conduct trials on the efficacy of a single-dose regimen for HPV vaccine in the 9-15 age group, considering global WHO guidelines supporting a single-dose regimen for public health programs.




Way Forward: Expand HPV vaccination to boys, enhance awareness, and ensure accessible healthcare, progressing towards comprehensive prevention of cervical cancer.


Scroll to Top